Cargando…

Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization

BACKGROUND: Portal vein system thrombosis (PVST) is a common postoperative complication brought by laparoscopic splenectomy and pericardial disconnection (LSD) among patients who suffered from portal hypertension and hypersplenism. This research lies mainly in probing into the risk factors of PVST a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yongning, Fu, Xueqin, Li, Ying, Liu, Peng, Liu, Songbai, Pan, Yaozhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652216/
https://www.ncbi.nlm.nih.gov/pubmed/35764840
http://dx.doi.org/10.1007/s00464-022-09340-5
_version_ 1784828419074162688
author Li, Yongning
Fu, Xueqin
Li, Ying
Liu, Peng
Liu, Songbai
Pan, Yaozhen
author_facet Li, Yongning
Fu, Xueqin
Li, Ying
Liu, Peng
Liu, Songbai
Pan, Yaozhen
author_sort Li, Yongning
collection PubMed
description BACKGROUND: Portal vein system thrombosis (PVST) is a common postoperative complication brought by laparoscopic splenectomy and pericardial disconnection (LSD) among patients who suffered from portal hypertension and hypersplenism. This research lies mainly in probing into the risk factors of PVST and evaluating the effects of warfarin on PVST prevention. MATERIALS AND METHODS: We took 131 individuals who have carried out LSD from January 2015 to January 2021. Patients were divided into warfarin group (n = 68) and aspirin group (n = 63). Meanwhile, thrombosis factors were analyzed in PVST arm (n = 48) and non-PVST arm (n = 83). RESULTS: We analyzed the early postoperative anticoagulation effect, 20 patients (29.4%) in the warfarin group developed PVST, and 28 patients (44.4%) in the aspirin group. The chance to PVST during the first year after operation was lower in the warfarin group than in the aspirin group (F = 13.43, P = 0.006). Risk factors for PVST were analyzed, and diabetes, the diameter of the portal vein and splenic vein, and the velocity of portal blood flow were statistically significant between the PVST arm and non-PVST arm (P <  < 0.05). Multiple logistic regression analyses have shown that diabetes, portal vein diameter, splenic vein diameter, and the velocity of portal blood flow were the risk factors of PVST. CONCLUSIONS: The portal vein diameter, splenic vein diameter, portal vein flow velocity, and diabetes are risk factors for the PVST after LSD. The prophylactic use of warfarin anticoagulation markedly decreases the probability of occurrence of the PVST in patients with portal hypertension after LSD compared to aspirin. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-022-09340-5.
format Online
Article
Text
id pubmed-9652216
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-96522162022-11-15 Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization Li, Yongning Fu, Xueqin Li, Ying Liu, Peng Liu, Songbai Pan, Yaozhen Surg Endosc Article BACKGROUND: Portal vein system thrombosis (PVST) is a common postoperative complication brought by laparoscopic splenectomy and pericardial disconnection (LSD) among patients who suffered from portal hypertension and hypersplenism. This research lies mainly in probing into the risk factors of PVST and evaluating the effects of warfarin on PVST prevention. MATERIALS AND METHODS: We took 131 individuals who have carried out LSD from January 2015 to January 2021. Patients were divided into warfarin group (n = 68) and aspirin group (n = 63). Meanwhile, thrombosis factors were analyzed in PVST arm (n = 48) and non-PVST arm (n = 83). RESULTS: We analyzed the early postoperative anticoagulation effect, 20 patients (29.4%) in the warfarin group developed PVST, and 28 patients (44.4%) in the aspirin group. The chance to PVST during the first year after operation was lower in the warfarin group than in the aspirin group (F = 13.43, P = 0.006). Risk factors for PVST were analyzed, and diabetes, the diameter of the portal vein and splenic vein, and the velocity of portal blood flow were statistically significant between the PVST arm and non-PVST arm (P <  < 0.05). Multiple logistic regression analyses have shown that diabetes, portal vein diameter, splenic vein diameter, and the velocity of portal blood flow were the risk factors of PVST. CONCLUSIONS: The portal vein diameter, splenic vein diameter, portal vein flow velocity, and diabetes are risk factors for the PVST after LSD. The prophylactic use of warfarin anticoagulation markedly decreases the probability of occurrence of the PVST in patients with portal hypertension after LSD compared to aspirin. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-022-09340-5. Springer US 2022-06-28 2022 /pmc/articles/PMC9652216/ /pubmed/35764840 http://dx.doi.org/10.1007/s00464-022-09340-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Li, Yongning
Fu, Xueqin
Li, Ying
Liu, Peng
Liu, Songbai
Pan, Yaozhen
Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization
title Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization
title_full Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization
title_fullStr Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization
title_full_unstemmed Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization
title_short Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization
title_sort early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652216/
https://www.ncbi.nlm.nih.gov/pubmed/35764840
http://dx.doi.org/10.1007/s00464-022-09340-5
work_keys_str_mv AT liyongning earlypreventionandriskfactorsanalysisofportalveinsystemthrombosisafterlaparoscopicsplenectomyandpericardialdevascularization
AT fuxueqin earlypreventionandriskfactorsanalysisofportalveinsystemthrombosisafterlaparoscopicsplenectomyandpericardialdevascularization
AT liying earlypreventionandriskfactorsanalysisofportalveinsystemthrombosisafterlaparoscopicsplenectomyandpericardialdevascularization
AT liupeng earlypreventionandriskfactorsanalysisofportalveinsystemthrombosisafterlaparoscopicsplenectomyandpericardialdevascularization
AT liusongbai earlypreventionandriskfactorsanalysisofportalveinsystemthrombosisafterlaparoscopicsplenectomyandpericardialdevascularization
AT panyaozhen earlypreventionandriskfactorsanalysisofportalveinsystemthrombosisafterlaparoscopicsplenectomyandpericardialdevascularization